Akutsu Koichi, Yamanaka Hiroyuki, Katayama Masahiko, Yamamoto Takeshi, Takayama Morimasa, Osaka Motohisa, Sato Naoki, Shimizu Wataru
Division of Cardiovascular Intensive Care, Nippon Medical School Hospital, Tokyo, Japan.
Cardiology and Intensive Care Units, Nippon Medical School Musashi Kosugi Hospital, Kanagawa, Japan; Department of Internal Medicine and Cardiology, Tsurumi University School of Dental Medicine, Kanagawa, Japan.
Am J Cardiol. 2016 Nov 1;118(9):1405-1409. doi: 10.1016/j.amjcard.2016.07.052. Epub 2016 Aug 12.
Previous reports have shown that serum elastin fragments (SEFs) may be a useful biomarker for the diagnosis of an acute aortic dissection (AAD). However, because the reference interval of SEFs has not been established, it has not been determined whether SEFs are really useful for the diagnosis of AAD. The purpose of this study was to determine the usefulness of measuring SEFs for the diagnosis of AAD. A total of 42 consecutive patients aged 68 ± 18 years who were diagnosed with an AAD were studied. Patient background and SEF levels were examined on admission. SEF levels were also measured in patients undergoing a medical examination (n = 531, age 54 ± 17 years) to compare with those with an AAD. In the control group, SEF levels increased with age (R = 0.725, p <0.001). Then, we defined the upper limit of the reference interval of SEF levels as the 97.5th percentile of control SEF grouped by decade of life from the sixth to ninth decade. The overall risk of AAD exceeding the upper limit of the reference interval at each decade was 10% (4 of 42). For patients in their 60s and 70s, median SEF levels in the AAD group (89 [77 to 104], 93 [60 to 123] ng/ml, respectively) were not significantly higher than those in the control group (79 [68 to 92], 90 [79 to 106] ng/ml, respectively; p = 0.081 and 0.990, respectively). Our data suggest that measuring SEF levels may not be useful in the diagnosis of an AAD as the upper limit of the reference interval of the SEF level was unexpectedly higher.
既往报道显示,血清弹性蛋白片段(SEFs)可能是诊断急性主动脉夹层(AAD)的一种有用生物标志物。然而,由于SEFs的参考区间尚未确定,因此尚未确定SEFs对AAD诊断是否真的有用。本研究的目的是确定检测SEFs对AAD诊断的有用性。共研究了42例连续诊断为AAD的患者,年龄68±18岁。入院时检查患者背景和SEF水平。还对接受体检的患者(n = 531,年龄54±17岁)进行了SEF水平测量,以与AAD患者进行比较。在对照组中,SEF水平随年龄增长而升高(R = 0.725,p<0.001)。然后,我们将SEF水平参考区间的上限定义为从第六个十年到第九个十年按年龄分组的对照SEF的第97.5百分位数。每个十年中AAD超过参考区间上限的总体风险为10%(42例中的4例)。对于60多岁和70多岁的患者,AAD组的SEF水平中位数(分别为89[77至104]、93[60至123]ng/ml)并不显著高于对照组(分别为79[68至92]、90[79至106]ng/ml;p分别为0.081和0.990)。我们的数据表明,由于SEF水平参考区间的上限出乎意料地高,检测SEF水平可能对AAD的诊断无用。